Valuation: Skinvisible Inc

Market Cap 973K 881K 815K 736K 1.39M 91.71M 1.44M 9.79M 3.88M 48.99M 3.65M 3.57M 156M P/E 2024
-3.02x
P/E 2025 -1.17x
Enterprise Value 6.75M 6.12M 5.66M 5.1M 9.62M 636M 9.96M 67.96M 26.95M 340M 25.33M 24.79M 1.08B EV / Sales 2024
376x
EV / Sales 2025 351x
Free-Float
96.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 77 1998-03-04
Director TitleAgeSince
Chairman 77 2009-11-09
Director/Board Member 53 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 973K
+1.05%+1.62%+14.72%+12.15% 389B
+0.97%-0.97%+26.42%+8.92% 263B
+1.20%-0.88%-3.79%+12.26% 140B
+1.81%+0.99%+26.87%+32.14% 77.82B
+2.09%-0.93%+5.10%-9.44% 65.78B
-1.54%-1.92%+25.10% - 54.31B
+0.96%+0.55%-17.80%-20.01% 49.34B
+1.12%+3.81%+21.45%-2.61% 40.04B
+0.93%+2.96%+21.23%+40.05% 22.45B
Average +0.71%-0.37%+13.26%+9.18% 123B
Weighted average by Cap. +0.50%-0.65%+14.87%+10.00%

Financials

2024 2025
Net sales 20K 18.12K 16.76K 15.12K 28.5K 1.89M 29.51K 201K 79.85K 1.01M 75.05K 73.46K 3.2M 20K 18.12K 16.76K 15.12K 28.5K 1.89M 29.51K 201K 79.85K 1.01M 75.05K 73.46K 3.2M
Net income -566K -513K -474K -428K -806K -53.33M -835K -5.7M -2.26M -28.49M -2.12M -2.08M -90.44M -1.06M -964K -892K -805K -1.52M -100M -1.57M -10.71M -4.25M -53.59M -3.99M -3.91M -170M
Net Debt 5.73M 5.19M 4.8M 4.33M 8.16M 540M 8.45M 57.67M 22.87M 288M 21.49M 21.04M 916M 5.78M 5.24M 4.84M 4.37M 8.23M 545M 8.52M 58.17M 23.06M 291M 21.68M 21.22M 924M
Logo Skinvisible Inc
Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical research and development (R&D) company. The Company has developed and patented a polymer delivery system, Invisicare, and formulated over forty topical skin products. Its flagship product, Invisicare, is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. Invisicare is specifically formulated to carry water-insoluble active and certain cationic active ingredients in water-based products without the use of alcohol, silicones, waxes, or other organic solvents. It is also exploring opportunities in medical markets outside the dermatology market, such as obesity and other potential markets.
Employees
-